Skip to content
OpenCapital
Get started

Enveric Biosciences ENVB Q1 2026 earnings

Reported May 15, 2026 · Before market open

EPS-$1.08

Next report

Aug 17, 2026 (In 2 weeks)

Versus estimates

Revenue

Q4 2024$340.4K

Diluted EPS

Q1 2026-$1.08
Q4 2025$0.85Beat by $56.65Q3 2025-$10.81Beat by $52.19Q2 2025-$11.64Beat by $51.36Q1 2025-$1.22Beat by $4.78Q4 2024-$21.89Miss by $18.44

Ask the moment Enveric Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Enveric Biosciences report Q1 2026 earnings?
Enveric Biosciences (ENVB) reported Q1 2026 earnings on May 15, 2026 before market open.
What were Enveric Biosciences's Q1 2026 revenue and EPS?
Enveric Biosciences reported eps of $-1.08 for Q1 2026.
How did Enveric Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 11.5% from $-1.22.
Where can I find Enveric Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-023345) and the 10-Q periodic report (0001493152-26-023353) directly on SEC EDGAR. The filing index links above go to sec.gov.